Physician

Anthony Kechante Njapa, D.O.

According to 2025 Medicare claims, Anthony Njapa, D.O. (NPI: 1881659019) practices general practice in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is ANJAN MEDICAL MANAGEMENT PLLC (NPI: 1649463993; TIN: 260630126) and primary practice location at 28401-7365. Njapa is affiliated with the Aledade A4548 NC Legacy MSSP Enhanced (ACO ID: A4548), participating under the MSSP model.

Njapa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 95 traditional Medicare patients, billed 505 HCPCS/CPT codes, and received $28,270 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,453 prescription claims across 305 beneficiaries totaling $844,350 in drug costs, led by Austedo (Deutetrabenazine). DME data shows 42 claims. Open Payments data shows 46 records totaling $1,358. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $177,545 to $844,350. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $20,928 to $6,998.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	126	846	$40,261
2016	126	714	$31,924
2017	292	1,181	$64,762
2018	316	1,827	$95,294
2019	285	1,869	$95,909
2020	218	1,294	$68,787
2021	187	1,108	$68,504
2022	130	763	$48,180
2023	102	668	$40,938
2024	95	505	$28,270

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	2,651	$177,545
2016	196	2,952	$192,951
2017	416	4,882	$350,498
2018	347	6,243	$536,592
2019	335	6,987	$692,840
2020	358	8,776	$1,017,849
2021	325	7,920	$974,656
2022	335	7,355	$1,049,269
2023	294	6,763	$1,061,446
2024	305	6,453	$844,350

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	222	$21,915
2016	33	195	$4,462
2017	28	123	$2,501
2018	41	128	$3,036
2019	145	259	$45,395
2020	27	165	$4,031
2021	14	74	$1,947
2022	11	36	$371
2023	N/R	28	$2,218
2024	N/R	42	$2,196

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	34	34	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	53	112	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	74	258	$54
G0444	Annual depression screening, 5 to 15 minutes	18	18	$17
96372	Injection of drug or substance under skin or into muscle	13	26	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Austedo	Deutetrabenazine	15	428	$86,419
Jardiance	Empagliflozin	73	4,066	$77,747
Rexulti	Brexpiprazole	22	875	$41,233
Linzess	Linaclotide	49	2,338	$40,393
Mounjaro	Tirzepatide	33	1,048	$38,786

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	21	$1,485
E1392	Portable oxygen concentrator, rental	Y	N/R	21	$711

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$1,358	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony Kechante Njapa, D.O.?

Tedicare shows public-source Medicare data for Anthony Kechante Njapa, D.O. (NPI 1881659019), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Kechante Njapa, D.O. have ACO affiliation data?

Anthony Kechante Njapa, D.O. is shown with ACO affiliation data for Aledade A4548 NC Legacy MSSP Enhanced (MSSP, ACO ID A4548).

What billing organization is linked to Anthony Kechante Njapa, D.O.?

Anthony Kechante Njapa, D.O. is linked to ANJAN MEDICAL MANAGEMENT PLLC (billing NPI 1649463993) in the available physician profile data.

Does Anthony Kechante Njapa, D.O. have Open Payments data?

Anthony Kechante Njapa, D.O. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.